Arenicin-1 vs Insulin Lispro
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Insulin Lispro |
|---|---|---|
| Category | Marine-Derived | Diabetes & Metabolic |
| Full Name | Arenicin-1 | Insulin lispro (B28-Lys, B29-Pro human insulin analog) |
| Molecular Weight | 2079 Da | 5808.0 Da |
| Half-Life | n/a | About 1 hour |
| Amino Acids | 21 | 51 |
| Typical Dose | n/a | 0.05-0.2 U/kg per meal |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 12000 |
| Research Status | Pre-clinical | Approved |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Insulin Lispro Benefits
- ✓Rapid postprandial glucose control
- ✓Flexible premeal timing
- ✓Predictable onset of action
- ✓Useful in basal-bolus regimens
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Insulin Lispro Dosing
Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin
Arenicin-1 Side Effects
- ⚠Arenicola marina
Insulin Lispro Side Effects
- ⚠Hypoglycemia
- ⚠Weight gain
- ⚠Injection-site reactions
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Insulin Lispro
Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.